The secretive system for vetting cancer drug use needs an urgent overhaul

(By Ed Silverman for STAT)

In the complicated world of medicine and money, the federal government relies on a handful of privately run directories to determine which cancer medicines it should pay for, and under which circumstances. Continue reading article here……

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.